Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD comparison of aspirin enteric-coated sustained-release vs standard enteric-coated tablets in healthy Chinese adults
ChiCTR2500112317Phase 4Completed
- Sponsor
- Beijing Luhe Hospital
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin (2 arms), sponsored by Beijing Luhe Hospital. Primary endpoints: Platelet maximum aggregation rate, Serum TXB2 levels and 6 more. Started Nov 2025; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on ChiCTR2500112317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112317.